We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer (VECTITAX)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01264328
Recruitment Status : Unknown
Verified April 2010 by Grupo Español de Tratamiento de Tumores de Cabeza y Cuello.
Recruitment status was:  Not yet recruiting
First Posted : December 21, 2010
Last Update Posted : December 21, 2010
Sponsor:
Collaborators:
Information provided by: